Aion Biosystems
Aion Biosystems is a medical device company that develops and markets TempShield, an FDA-cleared Class II wearable for continuous temperature monitoring, primarily serving cancer patients and other at-risk populations through enterprise sales to health systems, cancer centers, and skilled nursing facilities.
- Company typePrivate
- Founded2017
- HeadquartersDarien, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Aion Biosystems does
Aion Biosystems is a medical device company that develops and markets the TempShield, an FDA-cleared Class II wearable continuous temperature monitoring device. The skin-wearable patch provides 24/7 real-time body temperature tracking with up to 90 days of battery life per charge, transmitting data via Bluetooth to a companion mobile application (IDION Shield) and a clinician dashboard, with EMR integration. The device is primarily marketed to cancer patients undergoing chemotherapy, with secondary use cases in post-operative care, sepsis prevention, pediatrics, and long-term/skilled nursing facilities. The company sells through enterprise field sales to health systems and cancer centers, supplemented by channel partnerships (notably with care coordination platform Olio) and state-government investments such as the $2 million Florida deployment. Revenue is generated through hardware sales of the TempShield device plus recurring monitoring services that are reimbursable under CMS code 99454 for Remote Patient Monitoring.
Underlying the product is a proprietary wearable medical device platform developed by CTO Tom Blackadar (40 patents, 25+ years in wearable/medical devices) and a small engineering team. Clinical evidence cited by the company includes a 67% hospital prevention rate in a Trilogy Health Services program, a 90% reduction in cancer deaths in a Schenectady study, and ongoing programs with Ellis Medicine, Roswell Park Cancer Center, New York Cancer & Blood Specialists, and Florida Cancer Specialists. The company is headquartered in Lowell, Massachusetts (per its website), was founded in 2017, and operates as a privately held entity with 51-100 employees. FDA 510(k) clearance (K232010) was granted in August 2023, and the company has secured national distribution and is enrolling thousands of cancer patients as of 2025-2026.
Aion Biosystems firmographics
Firmographics- Name
- Aion Biosystems
- Legal name
- AION Biosystems Inc.
- Website
- https://aionbiosystems.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Aion Biosystems is a medical device company that develops and markets TempShield, an FDA-cleared Class II wearable for continuous temperature monitoring, primarily serving cancer patients and other at-risk populations through enterprise sales to health systems, cancer centers, and skilled nursing facilities.
- Ownership category
- akta.pro rank
Aion Biosystems industry classification
Industry- Product category
- Remote Patient Monitoring Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Continuous Temperature & Fever Monitoring (Wearable Thermometry) (HLAHACAK)
- akta.pro secondary industry
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)
Keywords
Where Aion Biosystems is headquartered
LocationHeadquarters
- HQ city
- Darien
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Aion Biosystems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- TempShield Device and Monitoring Services: Sale of FDA-cleared TempShield wearable device with associated monitoring services. Device is reimbursable under CMS code 99454 for Remote Patient Monitoring (RPM). Revenue generated from device sales and ongoing monitoring services billed through healthcare reimbursement channels.
- CMS Reimbursement (RPM): Reimbursable under CMS code 99454 for Remote Patient Monitoring services. Healthcare providers can bill for the monitoring service, creating recurring revenue opportunity aligned with device usage.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | CMS Reimbursable RPM Code 99454 |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
Aion Biosystems product offering
Product offeringCore offering
AION Biosystems develops and markets the FDA-cleared TempShield continuous temperature monitoring wearable device, an FDA Class II medical device that provides 24/7 real-time body temperature tracking for up to 90 days per charge. The device pairs with a mobile application and clinician dashboard via Bluetooth, with EMR integration, and is sold primarily to healthcare providers (cancer centers, health systems, long-term care facilities) with billing enabled under CMS reimbursement code 99454 for Remote Patient Monitoring.
Product overview
AION Biosystems offers the TempShield/iTempShield continuous temperature monitoring wearable system as its primary product offering. The system consists of an FDA-cleared skin-wearable device paired with a mobile application (IDION Shield) and a dedicated clinician dashboard. The TempShield device monitors patients 24/7 for up to 90 days, transmitting real-time temperature data via Bluetooth to the mobile app, which integrates with EMR systems and provides alerts to clinicians through the dashboard. The product targets cancer patients, post-operative patients, and those in long-term care or skilled nursing facilities to enable early detection of infections before they escalate to sepsis or hospitalization.
Differentiator
Problem solved
Functional benefit
Brands
- TempShield: FDA-cleared continuous temperature monitoring wearable device for cancer patients and others at risk of infection. Provides 24/7 real-time temperature tracking for up to 90 days per charge.
- iTempShield
Products and services
- AION TempShield (formerly iTempShield) FDA-cleared Class II medical device wearable providing 24/7 continuous body temperature monitoring for up to 90 days per charge. Targets cancer patients on chemotherapy, post-operative patients, pediatric patients, and those at risk of sepsis, with Bluetooth connectivity, mobile app integration, and EMR compatibility for healthcare providers.
Quantifiable outcome
- 67% hospital prevention rate among monitored residents in Trilogy Health Services program
- +4 more outcomes
Companies that use Aion Biosystems
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles3 records
Aion Biosystems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability2 records
Feature5 records
Aion Biosystems partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- OliocoreStrategic partnership to integrate FDA-cleared TempShield wearable temperature monitor into Olio's post-discharge coordination and Safe Return workflows. The partnership addresses the critical post-discharge blind spot for patients transitioning from skilled nursing facilities, enabling earlier detection and intervention for infections before they escalate to hospital readmissions.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Aion Biosystems competitors and assessment
Company assessmentEmerging players
- iRhythm Technologies: iRhythm's Zio long-term cardiac monitoring patch is an FDA-cleared wearable diagnostic used for continuous outpatient monitoring. It is a partial overlap peer that demonstrates the commercial model of FDA-cleared, reimbursable continuous-monitoring wearables in clinical use.
- Health Recovery Solutions: Health Recovery Solutions provides an RPM platform deployed across hospitals, SNFs, and home health. It targets post-discharge and chronic care use cases that overlap with Aion's TempShield SNF and post-acute positioning.
- Vivify Health: Vivify Health provides an RPM platform with connected device kits and clinician dashboards for health systems and payers. It overlaps with Aion's go-to-market in post-discharge and chronic condition monitoring, particularly where bundled devices and dashboards are required.
Broad incumbents
- Masimo: Masimo is a large incumbent in patient monitoring with a portfolio of continuous vital sign sensors, including the Radius VSM wearable platform. It competes with TempShield across hospital and post-acute care with broader product breadth and deeper sales coverage.
- Philips (Patient Monitoring): Philips offers continuous wearable patient monitoring through its Biosensor BX and broader RPM portfolio integrated with the Philips enterprise care platform. It is a broad incumbent in continuous patient monitoring that competes for the same health system contracts.
Direct peers
- VitalConnect: VitalConnect offers the VitalPatch wearable biosensor for continuous vital sign monitoring in hospital and remote settings. It targets similar clinical use cases around continuous monitoring of at-risk patients and competes for the same RPM and post-discharge monitoring contracts.
- Empatica: Empatica develops FDA-cleared wearable health monitors (EpiMonitor, Embrace) for continuous physiological monitoring. It serves clinical and research customers with wearable biosensors similar in form factor and clinical positioning to TempShield.
- BioIntelliSense: BioIntelliSense produces the BioSticker and BioButton continuous vital sign monitoring wearables for remote patient monitoring. It targets the same RPM market with FDA-cleared wearables and integrates with health system EMRs, directly competing for enterprise RPM contracts.
- Embr Labs: Embr Labs is the most direct peer: it builds temperature-based wearable technology for personal comfort and health. Notably, Aion's Lead Biomedical Engineer Kristen Warren was the first employee at Embr Labs, indicating deep category overlap in continuous temperature wearables.
- Current Health (Best Buy Health): Current Health offers an end-to-end RPM platform with a wearable continuous vital sign monitor and clinician dashboard, targeting hospital-at-home and post-discharge use cases. It competes directly with Aion for enterprise RPM contracts and integrates with EMRs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Aion Biosystems social profiles
Digital presenceAion Biosystems compliance and trust
Trust signalCompliance2 records
Aion Biosystems financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aion Biosystems leadership team
Management profileNumber of profiles
Profiles12 records
Aion Biosystems funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aion Biosystems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aion Biosystems
What does Aion Biosystems do?
AION Biosystems develops and markets the FDA-cleared TempShield continuous temperature monitoring wearable device, an FDA Class II medical device that provides 24/7 real-time body temperature tracking for up to 90 days per charge. The device pairs with a mobile application and clinician dashboard via Bluetooth, with EMR integration, and is sold primarily to healthcare providers (cancer centers, health systems, long-term care facilities) with billing enabled under CMS reimbursement code 99454 for Remote Patient Monitoring.
Is Aion Biosystems a public or private company?
Aion Biosystems is a private company. It is classified as venture growth investor backed and is currently operating.
When was Aion Biosystems founded?
Aion Biosystems was founded in 2017. It employs 51 to 100 people.
Where is Aion Biosystems based?
Aion Biosystems is headquartered in Darien, United States, in the North America region.
How does Aion Biosystems make money?
Two revenue lines are on record. TempShield Device and Monitoring Services are the primary driver. The others are CMS Reimbursement (RPM).
Who are Aion Biosystems's main competitors?
Emerging players on record are iRhythm Technologies, Health Recovery Solutions and Vivify Health. Broad incumbents are Masimo and Philips (Patient Monitoring). Direct peers are VitalConnect, Empatica, BioIntelliSense, Embr Labs and Current Health (Best Buy Health).
Does Aion Biosystems have an API?
No public API is recorded for Aion Biosystems.
What industry is Aion Biosystems in?
Aion Biosystems's product category is Remote Patient Monitoring Devices. Its primary akta.pro industry code is HLAHACAK, Continuous Temperature & Fever Monitoring (Wearable Thermometry), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.